GlaxoSmithKline (GSK)
GlaxoSmithKline Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | 2.184B | 2.028B | 2.271B | 1.921B | 2.536B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 377.04M | 801.31M | 918.22M | 762.91M | 208.13M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Non-Cash Items | 377.04M | 801.31M | 918.22M | 762.91M | 208.13M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | -688.09M | 173.05M | -923.85M | -707.33M | -1.383B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | -282.78M | 409.16M | 635.34M | 157.66M | 219.33M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Cash from Operating Activities | 1.590B | 3.412B | 2.901B | 2.134B | 1.580B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -248.21M | -498.30M | -273.77M | -295.40M | -252.95M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | -21.99M | 1.627B | -1.683B | 1.675B | -384.24M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Investments | -76.97M | -53.09M | -37.93M | 9.34M | 60.83M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Investing Activities | 551.42M | -1.823B | 1.614B | -1.778B | 1.913B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | 204.23M | -747.11M | -380.77M | -388.64M | 1.337B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Equity Issued | -218.36M | -3.333B | 1.515B | -764.00M | -517.12M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | -1.331B | -905.85M | -1.649B | -1.431B | -1.479B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Financing Activities | -370.75M | 2.108B | -2.717B | -798.09M | -86.45M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Cash from Financing Activities | -1.935B | -2.035B | -2.929B | -2.936B | -2.099B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | -40.84M | -74.94M | -42.85M | 6.95M | -62.43M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Change in Cash & Cash Equivalents | -182.23M | 554.46M | -450.96M | -1.183B | 755.67M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 8.807B | 9.317B | 8.993B | 8.482B | 9.049B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 8.625B | 8.993B | 8.482B | 9.049B | 10.05B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
